ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 406 filers reported holding ENCOMPASS HEALTH CORP in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $282,072 | -0.8% | 4,200 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $284,382 | +125178.4% | 4,200 | 0.0% | 0.01% | +16.7% |
| Q1 2023 | $227 | -9.6% | 4,200 | 0.0% | 0.01% | -14.3% |
| Q4 2022 | $251 | -99.9% | 4,200 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $235,000 | -24.9% | 4,200 | -4.5% | 0.01% | 0.0% |
| Q1 2022 | $313,000 | -4.0% | 4,400 | -12.0% | 0.01% | 0.0% |
| Q4 2021 | $326,000 | -18.1% | 5,000 | -5.7% | 0.01% | -30.0% |
| Q3 2021 | $398,000 | -3.9% | 5,300 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $414,000 | -4.6% | 5,300 | 0.0% | 0.01% | -16.7% |
| Q1 2021 | $434,000 | -12.5% | 5,300 | -11.7% | 0.01% | -14.3% |
| Q4 2020 | $496,000 | +27.2% | 6,000 | 0.0% | 0.01% | +7.7% |
| Q3 2020 | $390,000 | -3.2% | 6,000 | -7.7% | 0.01% | -13.3% |
| Q2 2020 | $403,000 | -3.1% | 6,500 | 0.0% | 0.02% | -21.1% |
| Q1 2020 | $416,000 | – | 6,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 798,931 | $53,656,206 | 4.60% |
| Orchard Capital Management, LLC | 135,466 | $9,097,897 | 3.36% |
| Sivik Global Healthcare LLC | 90,000 | $6,044 | 3.05% |
| BERNZOTT CAPITAL ADVISORS | 128,663 | $8,641,007 | 2.98% |
| REINHART PARTNERS, LLC. | 746,752 | $50,151,893 | 2.60% |
| Integral Health Asset Management, LLC | 250,000 | $16,790,000 | 2.32% |
| Leeward Investments, LLC - MA | 562,001 | $37,743,987 | 1.93% |
| Copeland Capital Management, LLC | 1,277,690 | $85,809,665 | 1.84% |
| Magnetar Financial LLC | 1,060,733 | $71,238,828 | 1.82% |
| Advantage Alpha Capital Partners LP | 122,252 | $8,210,444 | 1.72% |